Last reviewed · How we verify

NCT04293081

Preemptive Chlorepheniramine Maleate Reducing Postoperative Agitation

Completed NA Last updated 11 August 2020
What this trial tests

NA trial testing Preemptive chlorepheniramine maleate intravenous injection in Agitated; State, Acute Reaction to Stress in 90 participants. Completed in 30 July 2019.

Timeline
16 January 2019
Primary endpoint
31 May 2019
30 July 2019

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment90
Start date16 January 2019
Primary completion31 May 2019
Estimated completion30 July 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 60, any sex, with Agitated; State, Acute Reaction to Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to identify the role of preoperative chlorepheniramine maleate on alleviating or reducing the severity of postoperative agitation following FESS procedures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04293081.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing